Thalassemia an update: molecular basis, clinical features and treatment

Abstract

Thalassemia are a group of inherited blood disorders caused by the decrease or absence of beta-globin chain synthesis will be determined with decrease in erythrocyte hemoglobin, decreased production of erythrocytes and anemia. More thalassemia is inherited as recessive autosomal. According to this fact that which one of the chains are involved, they invide into two type including alpha and beta thalassemia, which each of them including several types. Thalassemia major is more extensive and patient needs to blood transfusion, but thalassemia minor is slight. The most important problem in this patient include iron overload, cardiac arrhythmia, hepatitis, osteoporosis and endocrine disorder however there are typical signs and symptoms of anemia. Treatment including Change of expression and production of HbF, Hematopoietic stem cell transplantation and Maintenance Treatment such as chelators therapy, Induction of fetal hemoglobin production by using Hydroxia urea, use of immunomodulator agents and Molecular Therapy by targeting of genes involving in HbF expression.in this article we review the thalassemia disorder and discuss on molecular basis, clinical features and treatment.

Authors and Affiliations

Kaveh Tari, Pooya Valizadeh Ardalan, Mahnoosh Abbaszadehdibavar, Amir Atashi, Ali Jalili, Maryam Gheidishahran

Keywords

Related Articles

Relationship between resilience and occupational stress among the faculty members of Ahvaz Jundishapur University of Medical Sciences

Introduction: Stress is seen in all occupations, especially in occupations associated with human health. Resilience is one of the coping strategies that helps a person to face stressful situations and to save on pathogen...

The role of folic acid in carcinogenesis, diagnosis, and treatment of cancer

Introduction: Folic acid, also known as folate, is one of the water-soluble B vitamins which its derivatives are involved in many metabolic reactions as cofactor, that are mostly contributed in cell growth. Regarding the...

Effect of acute and chronic coenzyme Q10 supplementation on creatine kinase after exhaustive aerobic activity

Introduction: Fatigue and muscle ache, is a common and prevalent experience after physical activity, especially exhausting activities. The purpose of this study was to investigate the acute and chronic effects of supplem...

Seroepidemiological study of toxoplasmosis in hemodialysis patients of Ahvaz, Southwest of Iran

Introduction: Toxoplasma gondii infects most warm-blooded vertebrates. Because of the immunodeficiency in hemodialysis patients, these individuals are at higher risk for reactivating chronic toxoplasmosis. Thus, the aim...

The correlation between rheumatoid factor and anti cyclic citrullinated peptides with gene expression of FoxP3 in rheumatoid artheritis patients

Introduction: Rheumatoid arthritis (RA) is a chronic autoimmune disorder that affect 1-2% of people worldwide. Inflammation is an important factor in the pathogenesis of RA. Anti- Cyclic Citrullinated Peptid (Anti-CCP) a...

Download PDF file
  • EP ID EP262280
  • DOI 10.22631/ijbmph.2018.56102
  • Views 81
  • Downloads 0

How To Cite

Kaveh Tari, Pooya Valizadeh Ardalan, Mahnoosh Abbaszadehdibavar, Amir Atashi, Ali Jalili, Maryam Gheidishahran (2018). Thalassemia an update: molecular basis, clinical features and treatment. International Journal of BioMedicine and Public Health (IJBMPH), 0(0), 48-58. https://europub.co.uk/articles/-A-262280